The availability of orphan drugs with high unmet need
HTA Consulting assessed the availability of orphan drugs with high unmet need (non-oncological drugs, the only one with orphan status registered after 2012 by EMA). Results from 32 countries were obtained - all EU and EFTA countries were analyzed except Cyprus (as of 10/04/2018)Average number